Neuropace, Inc. NPCE Deferred Tax Liabilities, Gross
Deferred Tax Liabilities, Gross at other companies
Other financials
Where this comes from
Reported directly by Neuropace, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DeferredIncomeTaxLiabilities.
The official record: Neuropace, Inc.’s 10-K, filed March 3, 2026, on SEC EDGAR. View the filing →
Ask your AI about Neuropace, Inc.'s deferred tax liabilities, gross.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Neuropace, Inc.'s deferred tax liabilities, gross?
- Neuropace, Inc. (NPCE) reported deferred tax liabilities, gross of $2.66M in Q4 2025.
- How has Neuropace, Inc.'s deferred tax liabilities, gross changed year-over-year?
- Neuropace, Inc.'s deferred tax liabilities, gross decreased by 11.7% year-over-year, from $3.01M to $2.66M.